{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:03:01Z","timestamp":1793300581299,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-18-566270"],"award-info":[{"award-number":["AARG-18-566270"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-21-851219"],"award-info":[{"award-number":["AARG-21-851219"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2018-12365527"],"award-info":[{"award-number":["RF-2018-12365527"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent clinical and experimental studies have highlighted the involvement of Ventral Tegmental Area (VTA) dopamine (DA) neurons for the early pathogenesis of Alzheimer\u2019s Disease (AD). We have previously described a progressive and selective degeneration of these neurons in the Tg2576 mouse model of AD, long before amyloid-beta plaque formation. The degenerative process in DA neurons is associated with an autophagy flux impairment, whose rescue can prevent neuronal loss. Impairments in autophagy can be the basis for accumulation of damaged mitochondria, leading to disturbance in calcium (Ca<jats:sup>2+<\/jats:sup>) homeostasis, and to functional and structural deterioration of DA neurons.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In Tg2576 mice, we performed amperometric recordings of DA levels and analysis of dopaminergic fibers in the Nucleus Accumbens \u2013 a major component of the ventral striatum precociously affected in AD patients \u2013 together with retrograde tracing, to identify the most vulnerable DA neuron subpopulations in the VTA. Then, we focused on these neurons to analyze mitochondrial integrity and Apoptosis-inducing factor (AIF) localization by electron and confocal microscopy, respectively. Stereological cell count was also used to evaluate degeneration of DA neuron subpopulations containing the Ca<jats:sup>2+<\/jats:sup>-binding proteins Calbindin-D28K and Calretinin. The expression levels for these proteins were analyzed by western blot and confocal microscopy. Lastly, using electrophysiology and microfluorometry we analyzed VTA DA neuron intrinsic properties and cytosolic free Ca<jats:sup>2+<\/jats:sup> levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found a progressive degeneration of mesolimbic DA neurons projecting to the ventral striatum, located in the paranigral nucleus and parabrachial pigmented subnucleus of the VTA. At the onset of degeneration (3\u2009months of age), the vulnerable DA neurons in the Tg2576 accumulate damaged mitochondria, while AIF translocates from the mitochondria to the nucleus. Although we describe an age-dependent loss of the DA neurons expressing Calbindin-D28K or Calretinin, we observed that the remaining cells upregulate the levels of Ca<jats:sup>2+<\/jats:sup>-binding proteins, and the free cytosolic levels of Ca<jats:sup>2+<\/jats:sup> in these neurons are significantly decreased. Coherently, TUNEL-stained Tg2576 DA\u00a0neurons express lower levels of Calbindin-D28K when compared with non-apoptotic cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall, our results suggest that the overexpression of Ca<jats:sup>2+<\/jats:sup>-binding proteins in VTA DA neurons might be an attempt of cells to survive by increasing their ability to buffer free Ca<jats:sup>2+<\/jats:sup>. Exploring strategies to overexpress Ca<jats:sup>2+<\/jats:sup>-binding proteins could be fundamental to reduce neuronal suffering and improve cognitive and non-cognitive functions in AD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13024-022-00580-6","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T21:31:03Z","timestamp":1669411863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer\u2019s disease in Tg2576 mice"],"prefix":"10.1186","volume":"17","author":[{"given":"Livia","family":"La Barbera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Cauzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Giacomet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Krashia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Melone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Viscomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenzo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-1832","authenticated-orcid":false,"given":"Marcello","family":"D\u2019Amelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"issue":"9533","key":"580_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H. Alzheimer\u2019s disease. Lancet Lond Engl. 2006;368(9533):387\u2013403.","journal-title":"Lancet Lond Engl."},{"issue":"7","key":"580_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2018;14(7):399\u2013415.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"580_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","volume":"12","author":"Z Ismail","year":"2016","unstructured":"Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195\u2013202.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"580_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(5):532\u20139.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"580_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.0000000000001238","volume":"84","author":"MC Masters","year":"2015","unstructured":"Masters MC, Morris JC, Roe CM. \u201cNoncognitive\u201d symptoms of early Alzheimer disease: a longitudinal analysis. Neurology. 2015;84(6):617\u201322.","journal-title":"Neurology."},{"issue":"10110","key":"580_CR6","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/S0140-6736(17)32399-1","volume":"390","author":"RM Anderson","year":"2017","unstructured":"Anderson RM, Hadjichrysanthou C, Evans S, Wong MM. Why do so many clinical trials of therapies for Alzheimer\u2019s disease fail? Lancet Lond Engl. 2017;390(10110):2327\u20139.","journal-title":"Lancet Lond Engl"},{"key":"580_CR7","doi-asserted-by":"crossref","unstructured":"Haass C, Selkoe D. If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? PLoS Biol. 2022;20(7):e3001694.","DOI":"10.1371\/journal.pbio.3001694"},{"issue":"4","key":"580_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"J Cummings","year":"2014","unstructured":"Cummings J, Morstorf T, Zhong K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6(4):37.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"580_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"3","author":"J Cummings","year":"2018","unstructured":"Cummings J, Lee G, Ritter A, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2018. Alzheimers Dement Transl Res Clin Interv. 2018;3(4):195\u2013214.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"3","key":"580_CR10","first-page":"157","volume":"6","author":"J Cummings","year":"2019","unstructured":"Cummings J, Blennow K, Johnson K, Keeley M, Bateman RJ, Molinuevo JL, et al. Anti-tau trials for Alzheimer\u2019s disease: a report from the EU\/US\/CTAD task force. J Prev Alzheimers Dis. 2019;6(3):157\u201363.","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"580_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med. 2013;369(4):341\u201350.","journal-title":"N Engl J Med"},{"issue":"1","key":"580_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jalz.2015.12.003","volume":"12","author":"S Gauthier","year":"2016","unstructured":"Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, et al. Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 2016;12(1):60\u20134.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"580_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, et al. Trial of Solanezumab for mild dementia due to Alzheimer\u2019s disease. N Engl J Med. 2018;378(4):321\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"580_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13195-016-0189-7","volume":"8","author":"R Vandenberghe","year":"2016","unstructured":"Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, et al. Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials. Alzheimers Res Ther. 2016;8(1):18.","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"580_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJMp2111320","volume":"385","author":"GD Rabinovici","year":"2021","unstructured":"Rabinovici GD. Controversy and Progress in Alzheimer\u2019s disease \u2014 FDA approval of Aducanumab. N Engl J Med. 2021;385(9):771\u20134.","journal-title":"N Engl J Med"},{"key":"580_CR16","doi-asserted-by":"publisher","first-page":"939855","DOI":"10.3389\/fnins.2022.939855","volume":"16","author":"L La Barbera","year":"2022","unstructured":"La Barbera L, Mauri E, D\u2019Amelio M, Gori M. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer\u2019s disease: current trends and future perspectives. Front Neurosci. 2022;16:939855.","journal-title":"Front Neurosci"},{"issue":"1","key":"580_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/JAD-180094","volume":"63","author":"M D\u2019Amelio","year":"2018","unstructured":"D\u2019Amelio M, Serra L, Bozzali M. Ventral tegmental area in prodromal Alzheimer\u2019s disease: bridging the gap between mice and humans. J Alzheimers Dis. 2018;63(1):181\u20133.","journal-title":"J Alzheimers Dis"},{"key":"580_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.phrs.2018.01.016","volume":"130","author":"M D\u2019Amelio","year":"2018","unstructured":"D\u2019Amelio M, Puglisi-Allegra S, Mercuri N. The role of dopaminergic midbrain in Alzheimer\u2019s disease: translating basic science into clinical practice. Pharmacol Res. 2018;130:414\u20139.","journal-title":"Pharmacol Res"},{"issue":"1","key":"580_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-171018","volume":"63","author":"M De Marco","year":"2018","unstructured":"De Marco M, Venneri A. Volume and connectivity of the ventral tegmental area are linked to neurocognitive signatures of Alzheimer\u2019s disease in humans. J Alzheimers Dis. 2018;63(1):167\u201380.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"580_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JAD-190954","volume":"75","author":"L Iaccarino","year":"2020","unstructured":"Iaccarino L, Sala A, Caminiti SP, Presotto L, Perani D. Alzheimer\u2019s Disease Neuroimaging Initiative. In vivo MRI structural and PET metabolic connectivity study of dopamine pathways in Alzheimer\u2019s disease. J Alzheimers Dis. 2020;75(3):1003\u201316.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"580_CR21","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1038\/ncomms14727","volume":"3","author":"A Nobili","year":"2017","unstructured":"Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, et al. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease. Nat Commun. 2017;3(8):14727.","journal-title":"Nat Commun"},{"issue":"1","key":"580_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13195-021-00925-1","volume":"13","author":"A Sala","year":"2021","unstructured":"Sala A, Caminiti SP, Presotto L, Pilotto A, Liguori C, Chiaravalloti A, et al. In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer\u2019s disease phases. Alzheimers Res Ther. 2021;13(1):187.","journal-title":"Alzheimers Res Ther"},{"key":"580_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2018.08.012","volume":"72","author":"L Serra","year":"2018","unstructured":"Serra L, D\u2019Amelio M, Di Domenico C, Dipasquale O, Marra C, Mercuri NB, et al. In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer\u2019s disease. Neurobiol Aging. 2018;72:72\u201382.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"580_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-210171","volume":"82","author":"L Serra","year":"2021","unstructured":"Serra L, D\u2019Amelio M, Esposito S, Di Domenico C, Koch G, Marra C, et al. Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to Alzheimer\u2019s disease: implications for treatment. J Alzheimers Dis JAD. 2021;82(3):985\u20131000.","journal-title":"J Alzheimers Dis JAD."},{"issue":"1","key":"580_CR25","doi-asserted-by":"publisher","first-page":"18707","DOI":"10.1038\/s41598-020-71368-1","volume":"10","author":"A Venneri","year":"2020","unstructured":"Venneri A, De Marco M. Reduced monoaminergic nuclei MRI signal detectable in pre-symptomatic older adults with future memory decline. Sci Rep. 2020;10(1):18707.","journal-title":"Sci Rep"},{"issue":"8","key":"580_CR26","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.celrep.2016.01.070","volume":"14","author":"JI Broussard","year":"2016","unstructured":"Broussard JI, Yang K, Levine AT, Tsetsenis T, Jenson D, Cao F, et al. Dopamine regulates aversive contextual learning and associated in vivo synaptic plasticity in the Hippocampus. Cell Rep. 2016;14(8):1930\u20139.","journal-title":"Cell Rep"},{"issue":"9","key":"580_CR27","doi-asserted-by":"publisher","first-page":"e2002365","DOI":"10.1371\/journal.pbio.2002365","volume":"15","author":"O Mamad","year":"2017","unstructured":"Mamad O, Stumpp L, McNamara HM, Ramakrishnan C, Deisseroth K, Reilly RB, et al. Place field assembly distribution encodes preferred locations. PLoS Biol. 2017;15(9):e2002365.","journal-title":"PLoS Biol"},{"issue":"12","key":"580_CR28","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/nn.3843","volume":"17","author":"CG McNamara","year":"2014","unstructured":"McNamara CG, Tejero-Cantero \u00c1, Trouche S, Campo-Urriza N, Dupret D. Dopaminergic neurons promote hippocampal reactivation and spatial memory persistence. Nat Neurosci. 2014;17(12):1658\u201360.","journal-title":"Nat Neurosci"},{"issue":"12","key":"580_CR29","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/nn.4152","volume":"18","author":"ZB Rosen","year":"2015","unstructured":"Rosen ZB, Cheung S, Siegelbaum SA. Midbrain dopamine neurons bidirectionally regulate CA3-CA1 synaptic drive. Nat Neurosci. 2015;18(12):1763\u201371.","journal-title":"Nat Neurosci"},{"issue":"9","key":"580_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrn3381","volume":"14","author":"SJ Russo","year":"2013","unstructured":"Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013;14(9):609\u201325.","journal-title":"Nat Rev Neurosci"},{"key":"580_CR31","doi-asserted-by":"crossref","unstructured":"Krashia P, Spoleti E, D'Amelio M. The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease. Front Psychiatry. 2022;13:1039725.","DOI":"10.3389\/fpsyt.2022.1039725"},{"key":"580_CR32","first-page":"12","volume":"17","author":"P Krashia","year":"2019","unstructured":"Krashia P, Nobili A, D\u2019Amelio M. Unifying hypothesis of dopamine neuron loss in neurodegenerative diseases: focusing on Alzheimer\u2019s disease. Front Mol Neurosci. 2019;17:12.","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"580_CR33","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.18632\/aging.101852","volume":"11","author":"M Bozzali","year":"2019","unstructured":"Bozzali M, D\u2019Amelio M, Serra L. Ventral tegmental area disruption in Alzheimer\u2019s disease. Aging. 2019;11(5):1325\u20136.","journal-title":"Aging."},{"issue":"1","key":"580_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/JAD-200276","volume":"77","author":"D Caligiore","year":"2020","unstructured":"Caligiore D, Silvetti M, D\u2019Amelio M, Puglisi-Allegra S, Baldassarre G. Computational modeling of Catecholamines dysfunction in Alzheimer\u2019s disease at pre-plaque stage. J Alzheimers Dis. 2020;77(1):275\u201390.","journal-title":"J Alzheimers Dis"},{"key":"580_CR35","doi-asserted-by":"publisher","unstructured":"Manca R, Valera-Bermejo JM, Venneri A, for the Alzheimer\u2019s Disease Neuroimaging Initiative. Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci. 2022 https:\/\/doi.org\/10.1007\/s00406-022-01417-5.","DOI":"10.1007\/s00406-022-01417-5"},{"key":"580_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2018.05.006","volume":"116","author":"A Cordella","year":"2018","unstructured":"Cordella A, Krashia P, Nobili A, Pignataro A, La Barbera L, Viscomi MT, et al. Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2018;116:142\u201354.","journal-title":"Neurobiol Dis"},{"issue":"350","key":"580_CR37","first-page":"113969","volume":"31","author":"E Spoleti","year":"2021","unstructured":"Spoleti E, Krashia P, La Barbera L, Nobili A, Lupascu CA, Giacalone E, et al. Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer\u2019s disease mouse model. Exp Neurol. 2021;31(350):113969.","journal-title":"Exp Neurol"},{"issue":"1","key":"580_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/braincomms\/fcaa039","volume":"2","author":"V Corsetti","year":"2020","unstructured":"Corsetti V, Borreca A, Latina V, Giacovazzo G, Pignataro A, Krashia P, et al. Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer\u2019s disease models. Brain Commun. 2020;2(1):1\u201334.","journal-title":"Brain Commun"},{"issue":"1","key":"580_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nn.2709","volume":"14","author":"M D\u2019Amelio","year":"2011","unstructured":"D\u2019Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease. Nat Neurosci. 2011;14(1):69\u201376.","journal-title":"Nat Neurosci"},{"issue":"13","key":"580_CR40","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1073\/pnas.0600948103","volume":"103","author":"JS Jacobsen","year":"2006","unstructured":"Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2006;103(13):5161\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"580_CR41","doi-asserted-by":"publisher","first-page":"19412","DOI":"10.1038\/s41598-021-99025-1","volume":"11","author":"Y Gloria","year":"2021","unstructured":"Gloria Y, Ceyz\u00e9riat K, Tsartsalis S, Millet P, Tournier BB. Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer\u2019s disease. Sci Rep. 2021;11(1):19412.","journal-title":"Sci Rep"},{"key":"580_CR42","doi-asserted-by":"crossref","unstructured":"Liu Y, Yoo M.-J, Savonenko A, Stirling W, Price DL, Borchelt DR, Mamounas L, Lyons WE, Blue ME, Lee MK. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci. 2008;28(51):13805\u201314","DOI":"10.1523\/JNEUROSCI.4218-08.2008"},{"key":"580_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2016.02.021","volume":"41","author":"P Moreno-Castilla","year":"2016","unstructured":"Moreno-Castilla P, Rodriguez-Duran LF, Guzman-Ramos K, Barcenas-Femat A, Escobar ML, Bermudez-Rattoni F. Dopaminergic neurotransmission dysfunction induced by amyloid-\u03b2 transforms cortical long-term potentiation into long-term depression and produces memory impairment. Neurobiol Aging. 2016;41:187\u201399.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"580_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/JAD-181246","volume":"70","author":"V Vorobyov","year":"2019","unstructured":"Vorobyov V, Bakharev B, Medvinskaya N, Nesterova I, Samokhin A, Deev A, et al. Loss of midbrain dopamine neurons and altered Apomorphine EEG effects in the 5xFAD mouse model of Alzheimer\u2019s disease. J Alzheimers Dis JAD. 2019;70(1):241\u201356.","journal-title":"J Alzheimers Dis JAD."},{"issue":"1","key":"580_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ejn.13364","volume":"45","author":"P Krashia","year":"2017","unstructured":"Krashia P, Martini A, Nobili A, Aversa D, D\u2019Amelio M, Berretta N, et al. On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. Eur J Neurosci. 2017;45(1):92\u2013105.","journal-title":"Eur J Neurosci"},{"issue":"5","key":"580_CR46","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.neuron.2008.01.022","volume":"57","author":"S Lammel","year":"2008","unstructured":"Lammel S, Hetzel A, H\u00e4ckel O, Jones I, Liss B, Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron. 2008;57(5):760\u201373.","journal-title":"Neuron."},{"issue":"36","key":"580_CR47","doi-asserted-by":"publisher","first-page":"8908","DOI":"10.1523\/JNEUROSCI.1526-08.2008","volume":"28","author":"EB Margolis","year":"2008","unstructured":"Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL. Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. J Neurosci. 2008;28(36):8908\u201313.","journal-title":"J Neurosci"},{"issue":"18","key":"580_CR48","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","volume":"25","author":"C Pacelli","year":"2015","unstructured":"Pacelli C, Gigu\u00e8re N, Bourque MJ, L\u00e9vesque M, Slack RS, Trudeau L\u00c9. Elevated mitochondrial bioenergetics and axonal Arborization size are key contributors to the vulnerability of dopamine neurons. Curr Biol CB. 2015;25(18):2349\u201360.","journal-title":"Curr Biol CB"},{"issue":"4","key":"580_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl). 2006;112(4):389\u2013404.","journal-title":"Acta Neuropathol (Berl)"},{"key":"580_CR50","doi-asserted-by":"publisher","first-page":"102031","DOI":"10.1016\/j.pneurobio.2021.102031","volume":"202","author":"L La Barbera","year":"2021","unstructured":"La Barbera L, Vedele F, Nobili A, Krashia P, Spoleti E, Latagliata EC, et al. Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer\u2019s disease. Prog Neurobiol. 2021;202:102031.","journal-title":"Prog Neurobiol"},{"key":"580_CR51","doi-asserted-by":"crossref","unstructured":"Nobili A, D\u2019Amelio M, Viscomi MT. Nilotinib: from animal-based studies to clinical investigation in Alzheimer\u2019s disease patients. Neural Regen Res [Internet] 2022 https:\/\/journals.lww.com\/nrronline\/Citation\/9000\/Nilotinib__from_animal_based_studies_to_clinical.99909.aspx.","DOI":"10.4103\/1673-5374.350700"},{"key":"580_CR52","first-page":"1","volume":"5","author":"A Nobili","year":"2021","unstructured":"Nobili A, La Barbera L, D\u2019Amelio M. Targeting autophagy as a therapeutic strategy to prevent dopamine neuron loss in early stages of Alzheimer disease. Autophagy. 2021;5:1\u20133.","journal-title":"Autophagy."},{"issue":"4","key":"580_CR53","doi-asserted-by":"publisher","first-page":"C817","DOI":"10.1152\/ajpcell.00139.2004","volume":"287","author":"PS Brookes","year":"2004","unstructured":"Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004;287(4):C817\u201333.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"580_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"RS Balaban","year":"2005","unstructured":"Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120(4):483\u201395.","journal-title":"Cell."},{"issue":"10","key":"580_CR55","doi-asserted-by":"publisher","first-page":"e25346","DOI":"10.1371\/journal.pone.0025346","volume":"6","author":"TW Kim","year":"2011","unstructured":"Kim TW, Moon Y, Kim K, Lee JE, Koh HC, Rhyu IJ, et al. Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson\u2019s diseases. PLoS One. 2011;6(10):e25346.","journal-title":"PLoS One"},{"issue":"3","key":"580_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13273-017-0034-5","volume":"13","author":"HI Yoo","year":"2017","unstructured":"Yoo HI, Ahn GY, Lee EJ, Kim E, Hong SY, Park SJ, et al. 6-Hydroxydopamine induces nuclear translocation of apoptosis inducing factor in nigral dopaminergic neurons in rat. Mol Cell Toxicol. 2017;13(3):305\u201315.","journal-title":"Mol Cell Toxicol"},{"issue":"1","key":"580_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2202-15-73","volume":"15","author":"W Yu","year":"2014","unstructured":"Yu W, Bonnet M, Farso M, Ma K, Chabot JG, Martin E, et al. The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer\u2019s disease. BMC Neurosci. 2014;15(1):73.","journal-title":"BMC Neurosci"},{"issue":"11","key":"580_CR58","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.cell.2022.04.020","volume":"185","author":"H Park","year":"2022","unstructured":"Park H, Kam TI, Peng H, Chou SC, Mehrabani-Tabari AA, Song JJ, et al. PAAN\/MIF nuclease inhibition prevents neurodegeneration in Parkinson\u2019s disease. Cell. 2022;185(11):1943\u20131959.e21.","journal-title":"Cell."},{"issue":"1","key":"580_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5115\/acb.2012.45.1.26","volume":"45","author":"JH Lee","year":"2012","unstructured":"Lee JH, Cheon YH, Woo RS, Song DY, Moon C, Baik TK. Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brain. Anat Cell Biol. 2012;45(1):26\u201337.","journal-title":"Anat Cell Biol"},{"issue":"5","key":"580_CR60","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2353\/ajpath.2010.090496","volume":"176","author":"W Yu","year":"2010","unstructured":"Yu W, Mechawar N, Krantic S, Quirion R. Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. Am J Pathol. 2010;176(5):2209\u201318.","journal-title":"Am J Pathol"},{"issue":"1","key":"580_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(00)80510-3","volume":"21","author":"MJ Berridge","year":"1998","unstructured":"Berridge MJ. Neuronal calcium signaling. Neuron. 1998;21(1):13\u201326.","journal-title":"Neuron."},{"issue":"1","key":"580_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ceca.2012.04.015","volume":"52","author":"T Cal\u00ec","year":"2012","unstructured":"Cal\u00ec T, Ottolini D, Brini M. Mitochondrial ca(2+) and neurodegeneration. Cell Calcium. 2012;52(1):73\u201385.","journal-title":"Cell Calcium"},{"key":"580_CR63","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fnins.2018.00470","volume":"12","author":"M M\u00fcller","year":"2018","unstructured":"M\u00fcller M, Ahumada-Castro U, Sanhueza M, Gonzalez-Billault C, Court FA, C\u00e1rdenas C. Mitochondria and calcium regulation as basis of neurodegeneration associated with aging. Front Neurosci. 2018;12:470.","journal-title":"Front Neurosci"},{"key":"580_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ceca.2017.06.008","volume":"70","author":"E Pchitskaya","year":"2018","unstructured":"Pchitskaya E, Popugaeva E, Bezprozvanny I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium. 2018;70:87\u201394.","journal-title":"Cell Calcium"},{"issue":"11","key":"580_CR65","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2005.09.021","volume":"27","author":"R Sultana","year":"2006","unstructured":"Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, et al. Redox proteomics identification of oxidized proteins in Alzheimer\u2019s disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging. 2006;27(11):1564\u201376.","journal-title":"Neurobiol Aging"},{"issue":"34","key":"580_CR66","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2009;106(34):14670\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"580_CR67","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00441-014-1866-0","volume":"357","author":"T Cal\u00ec","year":"2014","unstructured":"Cal\u00ec T, Ottolini D, Brini M. Calcium signaling in Parkinson\u2019s disease. Cell Tissue Res. 2014;357(2):439\u201354.","journal-title":"Cell Tissue Res"},{"issue":"10","key":"580_CR68","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1474-4422(07)70246-6","volume":"6","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ. Calcium, ageing, and neuronal vulnerability in Parkinson\u2019s disease. Lancet Neurol. 2007;6(10):933\u20138.","journal-title":"Lancet Neurol"},{"issue":"5284","key":"580_CR69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274(5284):99\u2013102.","journal-title":"Science."},{"issue":"1","key":"580_CR70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1083\/jcb.201502059","volume":"211","author":"V Pagliarini","year":"2015","unstructured":"Pagliarini V, Pelosi L, Bustamante MB, Nobili A, Berardinelli MG, D\u2019Amelio M, et al. SAM68 is a physiological regulator of SMN2 splicing in spinal muscular atrophy. J Cell Biol. 2015;211(1):77\u201390.","journal-title":"J Cell Biol"},{"issue":"4","key":"580_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41419-022-04830-9","volume":"13","author":"E Bisicchia","year":"2022","unstructured":"Bisicchia E, Mastrantonio R, Nobili A, Palazzo C, La Barbera L, Latini L, et al. Restoration of ER proteostasis attenuates remote apoptotic cell death after spinal cord injury by reducing autophagosome overload. Cell Death Dis. 2022;13(4):381.","journal-title":"Cell Death Dis"},{"key":"580_CR72","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2012","unstructured":"Paxinos G, Franklin K. The mouse brain in stereotaxic coordinates. 4th ed. United States: Elsevier\/Academic Press; 2012.","edition":"4"},{"issue":"1","key":"580_CR73","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","volume":"10","author":"P Krashia","year":"2019","unstructured":"Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, et al. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease. Nat Commun. 2019;10(1):3945.","journal-title":"Nat Commun"},{"issue":"8","key":"580_CR74","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1093\/cercor\/bhy203","volume":"29","author":"M Melone","year":"2019","unstructured":"Melone M, Ciriachi C, Pietrobon D, Conti F. Heterogeneity of astrocytic and neuronal GLT-1 at cortical excitatory synapses, as revealed by its Colocalization with Na+\/K+-ATPase \u03b1 isoforms. Cereb Cortex. 2019;29(8):3331\u201350.","journal-title":"Cereb Cortex"},{"issue":"3","key":"580_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/43.3.7532656","volume":"43","author":"KD Phend","year":"1995","unstructured":"Phend KD, Rustioni A, Weinberg RJ. An osmium-free method of epon embedment that preserves both ultrastructure and antigenicity for post-embedding immunocytochemistry. J Histochem Cytochem. 1995;43(3):283\u201392.","journal-title":"J Histochem Cytochem"},{"key":"580_CR76","first-page":"514","volume-title":"The fine structure of the nervous system: neurons and their supporting cells","author":"A Peters","year":"1991","unstructured":"Peters A, Palay SL, Webster H, deF. The fine structure of the nervous system: neurons and their supporting cells. 3rd ed. New York: OUP USA; 1991. p. 514.","edition":"3"},{"issue":"11","key":"580_CR77","doi-asserted-by":"publisher","first-page":"e1545","DOI":"10.1038\/cddis.2014.511","volume":"5","author":"V Cavallucci","year":"2014","unstructured":"Cavallucci V, Bisicchia E, Cencioni MT, Ferri A, Latini L, Nobili A, et al. Acute focal brain damage alters mitochondrial dynamics and autophagy in axotomized neurons. Cell Death Dis. 2014;5(11):e1545.","journal-title":"Cell Death Dis"},{"key":"580_CR78","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2013.11.006","volume":"64","author":"M Milanese","year":"2014","unstructured":"Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, et al. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2014;64:48\u201359.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"580_CR79","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-004-0837-z","volume":"107","author":"S Sasaki","year":"2004","unstructured":"Sasaki S, Warita H, Murakami T, Abe K, Iwata M. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol (Berl). 2004;107(5):461\u201374.","journal-title":"Acta Neuropathol (Berl)."},{"issue":"132","key":"580_CR80","first-page":"53825","volume":"26","author":"JT Ting","year":"2018","unstructured":"Ting JT, Lee BR, Chong P, Soler-Llavina G, Cobbs C, Koch C, et al. Preparation of acute brain slices using an optimized N-methyl-D-glucamine protective recovery method. J Vis Exp. 2018;26(132):53825.","journal-title":"J Vis Exp"},{"issue":"11","key":"580_CR81","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/acn3.50919","volume":"6","author":"M Romoli","year":"2019","unstructured":"Romoli M, Krashia P, Sen A, Franciotta D, Gastaldi M, Nobili A, et al. Hippocampal epileptogenesis in autoimmune encephalitis. Ann Clin Transl Neurol. 2019;6(11):2261\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"580_CR82","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuropharm.2015.12.013","volume":"103","author":"P Krashia","year":"2016","unstructured":"Krashia P, Ledonne A, Nobili A, Cordella A, Errico F, Usiello A, et al. Persistent elevation of D-aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. Neuropharmacology. 2016;103:69\u201378.","journal-title":"Neuropharmacology."},{"issue":"10","key":"580_CR83","doi-asserted-by":"publisher","first-page":"110094","DOI":"10.1016\/j.celrep.2021.110094","volume":"37","author":"M Di Filippo","year":"2021","unstructured":"Di Filippo M, Mancini A, Bellingacci L, Gaetani L, Mazzocchetti P, Zelante T, et al. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis. Cell Rep. 2021;37(10):110094.","journal-title":"Cell Rep"},{"issue":"3","key":"580_CR84","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.cell.2015.07.015","volume":"162","author":"KT Beier","year":"2015","unstructured":"Beier KT, Steinberg EE, DeLoach KE, Xie S, Miyamichi K, Schwarz L, et al. Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping. Cell. 2015;162(3):622\u201334.","journal-title":"Cell."},{"issue":"5","key":"580_CR85","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/cne.24572","volume":"527","author":"JM Breton","year":"2019","unstructured":"Breton JM, Charbit AR, Snyder BJ, Fong PTK, Dias EV, Himmels P, et al. Relative contributions and mapping of ventral tegmental area dopamine and GABA neurons by projection target in the rat. J Comp Neurol. 2019;527(5):916\u201341.","journal-title":"J Comp Neurol"},{"key":"580_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnana.2017.00025","volume":"11","author":"C Rodr\u00edguez-L\u00f3pez","year":"2017","unstructured":"Rodr\u00edguez-L\u00f3pez C, Clasc\u00e1 F, Prensa L. The Mesoaccumbens pathway: a retrograde labeling and single-cell axon tracing analysis in the mouse. Front Neuroanat. 2017;11:25.","journal-title":"Front Neuroanat"},{"key":"580_CR87","doi-asserted-by":"publisher","first-page":"612757","DOI":"10.3389\/fnins.2020.612757","volume":"14","author":"M Tran","year":"2021","unstructured":"Tran M, Reddy PH. Defective autophagy and Mitophagy in aging and Alzheimer\u2019s disease. Front Neurosci. 2021;14:612757.","journal-title":"Front Neurosci"},{"issue":"12","key":"580_CR88","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.4161\/15548627.2014.981787","volume":"10","author":"C Sarkar","year":"2014","unstructured":"Sarkar C, Zhao Z, Aungst S, Sabirzhanov B, Faden AI, Lipinski MM. Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy. 2014;10(12):2208\u201322.","journal-title":"Autophagy."},{"key":"580_CR89","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2018.03.016","volume":"30","author":"D Bano","year":"2018","unstructured":"Bano D, Prehn JHM. Apoptosis-inducing factor (AIF) in physiology and disease: the tale of a repented natural born killer. EBioMedicine. 2018;30:29\u201337.","journal-title":"EBioMedicine."},{"issue":"8","key":"580_CR90","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1074\/jbc.M413269200","volume":"280","author":"BM Polster","year":"2005","unstructured":"Polster BM, Basa\u00f1ez G, Etxebarria A, Hardwick JM, Nicholls DG. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem. 2005;280(8):6447\u201354.","journal-title":"J Biol Chem"},{"issue":"8","key":"580_CR91","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1021\/acschemneuro.9b00325","volume":"10","author":"KR Brimblecombe","year":"2019","unstructured":"Brimblecombe KR, Vietti-Michelina S, Platt NJ, Kastli R, Hnieno A, Gracie CJ, et al. Calbindin-D28K limits dopamine release in ventral but not dorsal striatum by regulating Ca2+ availability and dopamine transporter function. ACS Chem Neurosci. 2019;10(8):3419\u201326.","journal-title":"ACS Chem Neurosci"},{"key":"580_CR92","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fnana.2014.00146","volume":"8","author":"IG Dopeso-Reyes","year":"2014","unstructured":"Dopeso-Reyes IG, Rico AJ, Roda E, Sierra S, Pignataro D, Lanz M, et al. Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques. Front Neuroanat. 2014;8:146.","journal-title":"Front Neuroanat"},{"issue":"Pt 7","key":"580_CR93","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awt134","volume":"136","author":"MJ Hurley","year":"2013","unstructured":"Hurley MJ, Brandon B, Gentleman SM, Dexter DT. Parkinson\u2019s disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain J Neurol. 2013;136(Pt 7):2077\u201397.","journal-title":"Brain J Neurol"},{"issue":"2","key":"580_CR94","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0169-328X(95)00266-U","volume":"36","author":"MC Ng","year":"1996","unstructured":"Ng MC, Iacopino AM, Quintero EM, Marches F, Sonsalla PK, Liang CL, et al. The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons. Mol Brain Res. 1996;36(2):329\u201336.","journal-title":"Mol Brain Res"},{"issue":"2","key":"580_CR95","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-8993(90)91236-A","volume":"526","author":"T Yamada","year":"1990","unstructured":"Yamada T, McGeer PL, Baimbridge KG, McGeer EG. Relative sparing in Parkinson\u2019s disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 1990;526(2):303\u20137.","journal-title":"Brain Res"},{"issue":"1","key":"580_CR96","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12035-012-8332-3","volume":"47","author":"HH Yuan","year":"2013","unstructured":"Yuan HH, Chen RJ, Zhu YH, Peng CL, Zhu XR. The neuroprotective effect of overexpression of calbindin-D(28k) in an animal model of Parkinson\u2019s disease. Mol Neurobiol. 2013;47(1):117\u201322.","journal-title":"Mol Neurobiol"},{"issue":"24","key":"580_CR97","doi-asserted-by":"publisher","first-page":"8780","DOI":"10.1073\/pnas.82.24.8780","volume":"82","author":"CR Gerfen","year":"1985","unstructured":"Gerfen CR, Baimbridge KG, Miller JJ. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci U S A. 1985;82(24):8780\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"580_CR98","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1523\/JNEUROSCI.07-12-03935.1987","volume":"7","author":"CR Gerfen","year":"1987","unstructured":"Gerfen CR, Baimbridge KG, Thibault J. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci off. J Soc Neurosci. 1987;7(12):3935\u201344.","journal-title":"J Soc Neurosci"},{"issue":"2","key":"580_CR99","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0306-4522(96)00228-X","volume":"75","author":"CL Liang","year":"1996","unstructured":"Liang CL, Sinton CM, German DC. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin. Neuroscience. 1996;75(2):523\u201333.","journal-title":"Neuroscience."},{"issue":"1","key":"580_CR100","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0006-8993(99)01950-2","volume":"846","author":"C Nemoto","year":"1999","unstructured":"Nemoto C, Hida T, Arai R. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study. Brain Res. 1999;846(1):129\u201336.","journal-title":"Brain Res"},{"issue":"7423","key":"580_CR101","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature11527","volume":"491","author":"S Lammel","year":"2012","unstructured":"Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM, et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature. 2012;491(7423):212\u20137.","journal-title":"Nature."},{"issue":"7501","key":"580_CR102","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nature13257","volume":"509","author":"V Pascoli","year":"2014","unstructured":"Pascoli V, Terrier J, Espallergues J, Valjent E, O\u2019Connor EC, L\u00fcscher C. Contrasting forms of cocaine-evoked plasticity control components of relapse. Nature. 2014;509(7501):459\u201364.","journal-title":"Nature."},{"issue":"1","key":"580_CR103","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbr.2010.07.016","volume":"216","author":"G Alexander","year":"2011","unstructured":"Alexander G, Hanna A, Serna V, Younkin L, Younkin S, Janus C. Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer\u2019s disease. Behav Brain Res. 2011;216(1):77\u201383.","journal-title":"Behav Brain Res"},{"issue":"1","key":"580_CR104","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbr.2008.12.034","volume":"200","author":"G Taglialatela","year":"2009","unstructured":"Taglialatela G, Hogan D, Zhang WR, Dineley KT. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute Calcineurin inhibition. Behav Brain Res. 2009;200(1):95\u20139.","journal-title":"Behav Brain Res"},{"issue":"1","key":"580_CR105","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1567205013666160603010203","volume":"14","author":"GS Alves","year":"2017","unstructured":"Alves GS, Carvalho AF, Amorim de Carvalho L, Kenji Sudo F, Ibiapina Siqueira-Neto J, Oertel-Knochel V, et al. Neuroimaging findings related to behavioral disturbances in Alzheimer\u2019s disease: a systematic review. Curr Alzheimer Res. 2017;14(1):61\u201375.","journal-title":"Curr Alzheimer Res"},{"issue":"Suppl 1","key":"580_CR106","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1528-1167.2010.02909.x","volume":"52","author":"JL Noebels","year":"2011","unstructured":"Noebels JL. A perfect storm: converging paths of epilepsy and Alzheimer\u2019s dementia intersect in the hippocampal formation. Epilepsia. 2011;52(Suppl 1):39\u201346.","journal-title":"Epilepsia."},{"key":"580_CR107","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fcell.2020.00200","volume":"8","author":"G Chen","year":"2020","unstructured":"Chen G, Kroemer G, Kepp O. Mitophagy: An emerging role in aging and age-associated diseases. Front cell Dev Biol. 2020;8:200.","journal-title":"Front cell Dev Biol"},{"issue":"33","key":"580_CR108","doi-asserted-by":"publisher","first-page":"31401","DOI":"10.1074\/jbc.M301911200","volume":"278","author":"N Bid\u00e8re","year":"2003","unstructured":"Bid\u00e8re N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem. 2003;278(33):31401\u201311.","journal-title":"J Biol Chem"},{"issue":"12","key":"580_CR109","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/cdd.2008.123","volume":"15","author":"E Norberg","year":"2008","unstructured":"Norberg E, Gogvadze V, Ott M, Horn M, Uhl\u00e9n P, Orrenius S, et al. An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ. 2008;15(12):1857\u201364.","journal-title":"Cell Death Differ"},{"issue":"4","key":"580_CR110","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/0306-4522(96)00100-5","volume":"73","author":"A Mouatt-Prigent","year":"1996","unstructured":"Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC. Increased M-calpain expression in the mesencephalon of patients with Parkinson\u2019s disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience. 1996;73(4):979\u201387.","journal-title":"Neuroscience."},{"issue":"10","key":"580_CR111","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1523\/JNEUROSCI.23-10-04081.2003","volume":"23","author":"SJ Crocker","year":"2003","unstructured":"Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, et al. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson\u2019s disease. J Neurosci. 2003;23(10):4081\u201391.","journal-title":"J Neurosci"},{"issue":"9","key":"580_CR112","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ijms20092146","volume":"20","author":"R Fairless","year":"2019","unstructured":"Fairless R, Williams SK, Diem R. Calcium-binding proteins as determinants of central nervous system neuronal vulnerability to disease. Int J Mol Sci. 2019;20(9):2146.","journal-title":"Int J Mol Sci"},{"issue":"681","key":"580_CR113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neulet.2018.05.027","volume":"10","author":"F Zallo","year":"2018","unstructured":"Zallo F, Gardenal E, Verkhratsky A, Rodr\u00edguez JJ. Loss of calretinin and parvalbumin positive interneurones in the hippocampal CA1 of aged Alzheimer\u2019s disease mice. Neurosci Lett. 2018;10(681):19\u201325.","journal-title":"Neurosci Lett"},{"issue":"1","key":"580_CR114","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2008.04.020","volume":"371","author":"WS Choi","year":"2008","unstructured":"Choi WS, Lee E, Lim J, Oh YJ. Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity. Biochem Biophys Res Commun. 2008;371(1):127\u201331.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"580_CR115","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ana.410320410","volume":"32","author":"H Ito","year":"1992","unstructured":"Ito H, Goto S, Sakamoto S, Hirano A. Calbindin-D28k in the basal ganglia of patients with parkinsonism. Ann Neurol. 1992;32(4):543\u201350.","journal-title":"Ann Neurol"},{"issue":"10","key":"580_CR116","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/00001756-199110000-00012","volume":"2","author":"B Lavoie","year":"1991","unstructured":"Lavoie B, Parent A. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. Neuroreport. 1991;2(10):601\u20134.","journal-title":"Neuroreport."},{"issue":"648","key":"580_CR117","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1749-6632.1992.tb24523.x","volume":"11","author":"DC German","year":"1992","unstructured":"German DC, Manaye KF, Sonsalla PK, Brooks BA. Midbrain dopaminergic cell loss in Parkinson\u2019s disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci. 1992;11(648):42\u201362.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"580_CR118","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0169-328X(92)90033-8","volume":"13","author":"A Iacopino","year":"1992","unstructured":"Iacopino A, Christakos S, German D, Sonsalla PK, Altar CA. Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Brain Res Mol Brain Res. 1992;13(3):251\u201361.","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"580_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-019-0210-6","volume":"5","author":"S Jung","year":"2019","unstructured":"Jung S, Chung Y, Lee Y, Lee Y, Cho JW, Shin EJ, et al. Buffering of cytosolic calcium plays a neuroprotective role by preserving the autophagy-lysosome pathway during MPP+-induced neuronal death. Cell Death Discov. 2019;5(1):1\u201315.","journal-title":"Cell Death Discov"},{"issue":"9","key":"580_CR120","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1523\/JNEUROSCI.1345-19.2019","volume":"40","author":"KM Ricke","year":"2020","unstructured":"Ricke KM, Pa\u00df T, Kimoloi S, F\u00e4hrmann K, J\u00fcngst C, Schauss A, et al. Mitochondrial dysfunction combined with high calcium load leads to impaired antioxidant defense underlying the selective loss of Nigral dopaminergic neurons. J Neurosci. 2020;40(9):1975\u201386.","journal-title":"J Neurosci"},{"issue":"7148","key":"580_CR121","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, et al. \u201cRejuvenation\u201d protects neurons in mouse models of Parkinson\u2019s disease. Nature. 2007;447(7148):1081\u20136.","journal-title":"Nature."},{"issue":"1","key":"580_CR122","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/exnr.2002.8044","volume":"179","author":"PT Bywood","year":"2003","unstructured":"Bywood PT, Johnson SM. Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices. Exp Neurol. 2003;179(1):47\u201359.","journal-title":"Exp Neurol"},{"key":"580_CR123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fnmol.2019.00055","volume":"12","author":"C Catoni","year":"2019","unstructured":"Catoni C, Cal\u00ec T, Brini M. Calcium, Dopamine and neuronal calcium sensor 1: their contribution to Parkinson\u2019s disease. Front Mol Neurosci. 2019;12:55.","journal-title":"Front Mol Neurosci"},{"issue":"198","key":"580_CR124","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuroscience.2011.08.045","volume":"15","author":"DJ Surmeier","year":"2011","unstructured":"Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson\u2019s disease. Neuroscience. 2011;15(198):221\u201331.","journal-title":"Neuroscience."},{"issue":"6","key":"580_CR125","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nn.3099","volume":"15","author":"PY Pan","year":"2012","unstructured":"Pan PY, Ryan TA. Calbindin controls release probability in ventral tegmental area dopamine neurons. Nat Neurosci. 2012;15(6):813\u20135.","journal-title":"Nat Neurosci"},{"issue":"43","key":"580_CR126","doi-asserted-by":"publisher","first-page":"14304","DOI":"10.1523\/JNEUROSCI.0930-14.2014","volume":"34","author":"A Berthet","year":"2014","unstructured":"Berthet A, Margolis EB, Zhang J, Hsieh I, Zhang J, Hnasko TS, et al. Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons. J Neurosci. 2014;34(43):14304\u201317.","journal-title":"J Neurosci"},{"issue":"4","key":"580_CR127","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1523\/JNEUROSCI.22-04-01290.2002","volume":"22","author":"H Neuhoff","year":"2002","unstructured":"Neuhoff H, Neu A, Liss B, Roeper J. I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci. 2002;22(4):1290\u2013302.","journal-title":"J Neurosci"},{"issue":"11","key":"580_CR128","first-page":"1510","volume":"9","author":"YZ Wang","year":"1995","unstructured":"Wang YZ, Christakos S. Retinoic acid regulates the expression of the calcium binding protein, calbindin-D28K. Mol Endocrinol Baltim Md. 1995;9(11):1510\u201321.","journal-title":"Mol Endocrinol Baltim Md"},{"issue":"8","key":"580_CR129","first-page":"OE07","volume":"10","author":"AB Bhatti","year":"2016","unstructured":"Bhatti AB, Usman M, Ali F, Satti SA. Vitamin supplementation as an adjuvant treatment for Alzheimer\u2019s disease. J Clin Diagn Res JCDR. 2016;10(8):OE07\u201311.","journal-title":"J Clin Diagn Res JCDR"},{"issue":"3","key":"580_CR130","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ageing\/30.3.235","volume":"30","author":"I Bourdel-Marchasson","year":"2001","unstructured":"Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing. 2001;30(3):235\u201341.","journal-title":"Age Ageing"},{"issue":"2","key":"580_CR131","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1447-0594.2011.00786.x","volume":"12","author":"K Ono","year":"2012","unstructured":"Ono K, Yamada M. Vitamin a and Alzheimer\u2019s disease. Geriatr Gerontol Int. 2012;12(2):180\u20138.","journal-title":"Geriatr Gerontol Int"},{"issue":"2","key":"580_CR132","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-2011-110455","volume":"27","author":"J Takasaki","year":"2011","unstructured":"Takasaki J, Ono K, Yoshiike Y, Hirohata M, Ikeda T, Morinaga A, et al. Vitamin a has anti-oligomerization effects on amyloid-\u03b2 in vitro. J Alzheimers Dis JAD. 2011;27(2):271\u201380.","journal-title":"J Alzheimers Dis JAD"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-022-00580-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T21:43:11Z","timestamp":1669412591000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-022-00580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":132,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1186\/s13024-022-00580-6","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocol were approved by the Italian Ministry of Health (protocol #535\/2019PR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}